Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of June 11, 2025 • 7:31 PM ET
As of June 11, 2025 • 7:31 PM ET
Date/Time | Source | News Release |
---|---|---|
05/12/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Monday, May 12th, 2025 |
05/12/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - iBio Inc. |
05/02/2025 08:06 AM EDT | SeekingAlpha | iBio GAAP EPS of -$0.49 misses by $0.24 |
04/29/2025 02:30 PM EDT | PRISM News | PRISM Mid-Day Movers: Weight Loss Index Gains on GLP-1 Offerings |
04/28/2025 02:00 PM EDT | PRISM News | PRISM Mid-Day Movers: Strategic Deals in Energy and Pharma Contrast Broader Market Cooldown |
04/22/2025 03:00 PM EDT | PRISM News | PRISM Mid-Day Movers: AI Auto Assistants and Obesity Innovation Spark Index Volatility |
04/22/2025 12:31 PM EDT | PRISM News | iBio Adds New Obesity Drug Candidate to Pipeline, Targets Fat Loss Without Muscle Loss |
02/10/2025 05:19 PM EST | SeekingAlpha | iBio GAAP EPS of -$0.48 |
01/31/2025 05:25 PM EST | SeekingAlpha | iBio files for secondary offering |
01/02/2025 07:04 AM EST | SeekingAlpha | iBio expands cardiometabolic and obesity program |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.